J
John K. Iskander
Researcher at Centers for Disease Control and Prevention
Publications - 137
Citations - 7415
John K. Iskander is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Vaccination & Public health. The author has an hindex of 35, co-authored 130 publications receiving 6932 citations. Previous affiliations of John K. Iskander include United States Public Health Service.
Papers
More filters
Journal Article
Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009.
Anthony E. Fiore,Timothy M. Uyeki,Karen R. Broder,Lyn Finelli,Gary L. Euler,James A. Singleton,John K. Iskander,Pascale M. Wortley,David K. Shay,Joseph S. Bresee,Nancy J. Cox +10 more
TL;DR: This report updates the 2008 recommendations by CDC's Advisory Committee on Immunization Practices regarding the use of influenza vaccine for the prevention and control of seasonal influenza and includes a summary of safety data for U.S. licensed influenza vaccines.
Journal Article
Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).
Karen R. Broder,Margaret M. Cortese,John K. Iskander,Katrina Kretsinger,Barbara A. Slade,Kristin Brown,Christina M Mijalski,Tejpratap S P Tiwari,Emily J Weston,Amanda C. Cohn,Pamela U. Srivastava,John S. Moran,Benjamin Schwartz,Trudy V. Murphy +13 more
TL;DR: Adolescents aged 11-18 years should receive a single dose of Tdap instead of tetanus and diphtheria toxoids vaccine (Td) for booster immunization against tetanus, diphTheria, and pertussis if they have completed the recommended childhood DTP/DTaP vaccination series.
Journal ArticleDOI
Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine.
Barbara A. Slade,Laura Leidel,Claudia Vellozzi,Emily Jane Woo,Wei Hua,Andrea Sutherland,Hector S. Izurieta,Robert Ball,Nancy Miller,M. Miles Braun,Lauri E. Markowitz,John K. Iskander +11 more
TL;DR: Most of the AEFI rates were not greater than the background rates compared with other vaccines, but there was disproportional reporting of syncope and venous thromboembolic events.
Journal Article
Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
Weigong Zhou,Vitali Pool,John K. Iskander,Roseanne English-Bullard,Robert Ball,Robert P. Wise,Penina Haber,Robert Pless,Gina T. Mootrey,Susan S. Ellenberg,M. Miles Braun,Robert T. Chen +11 more
TL;DR: This report summarizes the adverse events reported to the Vaccine Adverse Event Reporting System (VAERS) from January 1, 1991, through December 31, 2001, and indicates that the most commonly reported adverse event was fever, which appeared in 25.8% of all reports.
Journal ArticleDOI
Understanding vaccine safety information from the Vaccine Adverse Event Reporting System.
Frederick Varricchio,John K. Iskander,Frank DeStefano,Robert Ball,Robert Pless,M. Miles Braun,Robert T. Chen +6 more
TL;DR: The Vaccine Adverse Event Reporting System is useful in detecting adverse events related to vaccines and most recently was used for enhanced reporting of adverse events in the national smallpox immunization campaign.